XCUBE
Live / Registered — Registered (as of 07 Apr 2026)
What this means for you
Registered since 07 Apr 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79320193
- Registration number
- 8200099
- Mark type
- Stylized text
- Filed
- 25 Feb 2021
- Published for opposition
- 17 Feb 2026
- Registered
- 07 Apr 2026
- Attorney of record
- Anna Kurian Shaw
Goods and services
- Class 009 — Scientific and electric apparatus: Recorded bioinformatics software for data processing, data engineering, data science, predictive modeling and statistical modeling and machine learning in the field of immunotherapies; recorded graphical user interface software for data processing, data engineering, data science, predictive modeling and statistical modeling and machine learning in the field of immunotherapies; recorded artificial intelligence and machine learning software for genome analysis, developing personal treatment strategies for patients with diagnosed cancer, analyzing, screening, identifying, quantifying, and interpreting data in the field of mass spectrometry and next-generation sequencing (NGS); electronic databases for bioinformatic purposes; next-generation sequencing (NGS) data processor; bioinformatics data processor; none of the foregoing in connection with HVAC systems or components thereof
- Class 035 — Advertising and business services: Compilation of statistical data and models with respect to cancer treatment and cancer diagnosis
- Class 042 — Scientific and technological services: Computer programming in the medical, pharmaceutical and biotechnological field; database design in the medical, pharmaceutical and biotechnological field; maintenance of database software in the medical, pharmaceutical, and biotechnological field; programming of software for importing and managing data in the medical, pharmaceutical, and biotechnological field; information technology [IT] consulting services for the pharmaceutical and healthcare industries relating to data processing, data engineering, data science, predictive modeling and statistical modeling and machine learning in the field of immunotherapies; computer programming for data processing; conducting evaluations in the field of pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development and evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; conducting clinical trials in the field of pharmaceuticals for the treatment and prevention of cancer; providing scientific molecular and genomic information for medical and clinical research, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; research and development of medicines and diagnostic agents for cancer treatment and cancer diagnosis; providing scientific advice in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis in the field of next-generation sequencing (NGS) with respect to the analysis and interpretation of genomic data obtained from cancer patients; providing an online, non-downloadable computer software platform for purposes of storing and providing information about an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice; research and development services in the field of immunology; none of the foregoing in connection with HVAC systems or components thereof
- Class 044 — Medical, beauty and agricultural services: Medical and pharmaceutical consultancy services
Owner
Prosecution history
- 27 Aug 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 06 Aug 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 07 Jul 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 07 Apr 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Apr 2026 — REGISTERED-PRINCIPAL REGISTER
- 17 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Feb 2026 — PUBLISHED FOR OPPOSITION
- 11 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Jul 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 08 Jul 2025 — NON-FINAL ACTION E-MAILED
- 08 Jul 2025 — NON-FINAL ACTION WRITTEN